Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

FRA:BC8 - Deutsche Boerse Ag - DE0005158703 - Common Stock - Currency: EUR

36.8  -0.2 (-0.54%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BC8. BC8 was compared to 72 industry peers in the IT Services industry. While BC8 has a great health rating, its profitability is only average at the moment. BC8 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BC8 was profitable.
In the past year BC8 had a positive cash flow from operations.
In the past 5 years BC8 has always been profitable.
In the past 5 years BC8 always reported a positive cash flow from operatings.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of BC8 (6.54%) is better than 70.83% of its industry peers.
With a decent Return On Equity value of 13.65%, BC8 is doing good in the industry, outperforming 62.50% of the companies in the same industry.
BC8 has a better Return On Invested Capital (9.60%) than 61.11% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BC8 is in line with the industry average of 11.13%.
Industry RankSector Rank
ROA 6.54%
ROE 13.65%
ROIC 9.6%
ROA(3y)7.31%
ROA(5y)7.24%
ROE(3y)16.22%
ROE(5y)16.41%
ROIC(3y)12.71%
ROIC(5y)12.08%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

The Profit Margin of BC8 (3.92%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BC8 has grown nicely.
BC8's Operating Margin of 5.61% is in line compared to the rest of the industry. BC8 outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of BC8 has grown nicely.
The Gross Margin of BC8 (17.71%) is worse than 77.78% of its industry peers.
BC8's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.61%
PM (TTM) 3.92%
GM 17.71%
OM growth 3Y5.1%
OM growth 5Y7.51%
PM growth 3Y2.73%
PM growth 5Y5.44%
GM growth 3Y0.99%
GM growth 5Y3.27%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BC8 is creating value.
The number of shares outstanding for BC8 remains at a similar level compared to 1 year ago.
The number of shares outstanding for BC8 remains at a similar level compared to 5 years ago.
Compared to 1 year ago, BC8 has a worse debt to assets ratio.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

BC8 has an Altman-Z score of 4.34. This indicates that BC8 is financially healthy and has little risk of bankruptcy at the moment.
BC8 has a better Altman-Z score (4.34) than 90.28% of its industry peers.
BC8 has a debt to FCF ratio of 1.17. This is a very positive value and a sign of high solvency as it would only need 1.17 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.17, BC8 belongs to the top of the industry, outperforming 84.72% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that BC8 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.29, BC8 is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.17
Altman-Z 4.34
ROIC/WACC1.5
WACC6.41%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

BC8 has a Current Ratio of 2.00. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
BC8's Current ratio of 2.00 is amongst the best of the industry. BC8 outperforms 84.72% of its industry peers.
A Quick Ratio of 1.64 indicates that BC8 should not have too much problems paying its short term obligations.
BC8 has a Quick ratio of 1.64. This is in the better half of the industry: BC8 outperforms 79.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.64
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

BC8 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.86%.
BC8 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.31% yearly.
The Revenue has been growing slightly by 1.42% in the past year.
The Revenue has been growing by 8.24% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.86%
EPS 3Y11.57%
EPS 5Y14.31%
EPS Q2Q%-16.98%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y8.34%
Revenue growth 5Y8.24%
Sales Q2Q%2.17%

3.2 Future

The Earnings Per Share is expected to grow by 2.52% on average over the next years.
Based on estimates for the next years, BC8 will show a small growth in Revenue. The Revenue will grow by 2.91% on average per year.
EPS Next Y-7.28%
EPS Next 2Y-1.22%
EPS Next 3Y2.52%
EPS Next 5YN/A
Revenue Next Year-0.79%
Revenue Next 2Y1.9%
Revenue Next 3Y3.29%
Revenue Next 5Y2.91%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.49, the valuation of BC8 can be described as rather expensive.
65.28% of the companies in the same industry are more expensive than BC8, based on the Price/Earnings ratio.
BC8's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.81.
BC8 is valuated rather expensively with a Price/Forward Earnings ratio of 17.79.
BC8's Price/Forward Earnings is on the same level as the industry average.
BC8's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.91.
Industry RankSector Rank
PE 18.49
Fwd PE 17.79
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BC8's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BC8 indicates a somewhat cheap valuation: BC8 is cheaper than 63.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.95
EV/EBITDA 9.44
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The decent profitability rating of BC8 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.29
EPS Next 2Y-1.22%
EPS Next 3Y2.52%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 1.86%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.21, BC8 has a dividend in line with its industry peers.
BC8's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.86%

5.2 History

The dividend of BC8 is nicely growing with an annual growth rate of 16.72%!
Dividend Growth(5Y)16.72%
Div Incr Years4
Div Non Decr Years5
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BC8 pays out 35.25% of its income as dividend. This is a sustainable payout ratio.
BC8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP35.25%
EPS Next 2Y-1.22%
EPS Next 3Y2.52%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (3/27/2025, 7:00:00 PM)

36.8

-0.2 (-0.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-14 2025-03-14/amc
Earnings (Next)05-09 2025-05-09
Inst Owners41.11%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.64B
Analysts77
Price Target42.91 (16.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.86%
Yearly Dividend0.65
Dividend Growth(5Y)16.72%
DP35.25%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.81%
Min EPS beat(2)-9.76%
Max EPS beat(2)-3.86%
EPS beat(4)1
Avg EPS beat(4)-4.3%
Min EPS beat(4)-9.76%
Max EPS beat(4)0.13%
EPS beat(8)2
Avg EPS beat(8)-1.99%
EPS beat(12)5
Avg EPS beat(12)-0.27%
EPS beat(16)9
Avg EPS beat(16)2.12%
Revenue beat(2)1
Avg Revenue beat(2)-7.83%
Min Revenue beat(2)-16.2%
Max Revenue beat(2)0.55%
Revenue beat(4)2
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-16.2%
Max Revenue beat(4)1.78%
Revenue beat(8)4
Avg Revenue beat(8)0.03%
Revenue beat(12)6
Avg Revenue beat(12)-4.82%
Revenue beat(16)6
Avg Revenue beat(16)-8.95%
PT rev (1m)0%
PT rev (3m)-2.2%
EPS NQ rev (1m)-2.12%
EPS NQ rev (3m)-3.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.52%
Revenue NQ rev (1m)-3.53%
Revenue NQ rev (3m)-7.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 18.49
Fwd PE 17.79
P/S 0.73
P/FCF 9.95
P/OCF 8.31
P/B 2.53
P/tB 5.08
EV/EBITDA 9.44
EPS(TTM)1.99
EY5.41%
EPS(NY)2.07
Fwd EY5.62%
FCF(TTM)3.7
FCFY10.05%
OCF(TTM)4.43
OCFY12.04%
SpS50.67
BVpS14.55
TBVpS7.25
PEG (NY)N/A
PEG (5Y)1.29
Profitability
Industry RankSector Rank
ROA 6.54%
ROE 13.65%
ROCE 13.47%
ROIC 9.6%
ROICexc 11.94%
ROICexgc 20.94%
OM 5.61%
PM (TTM) 3.92%
GM 17.71%
FCFM 7.3%
ROA(3y)7.31%
ROA(5y)7.24%
ROE(3y)16.22%
ROE(5y)16.41%
ROIC(3y)12.71%
ROIC(5y)12.08%
ROICexc(3y)16.48%
ROICexc(5y)15.47%
ROICexgc(3y)28.38%
ROICexgc(5y)26.41%
ROCE(3y)17.83%
ROCE(5y)16.95%
ROICexcg growth 3Y-0.97%
ROICexcg growth 5Y2.09%
ROICexc growth 3Y-0.91%
ROICexc growth 5Y2.57%
OM growth 3Y5.1%
OM growth 5Y7.51%
PM growth 3Y2.73%
PM growth 5Y5.44%
GM growth 3Y0.99%
GM growth 5Y3.27%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.17
Debt/EBITDA 1.07
Cap/Depr 68.2%
Cap/Sales 1.45%
Interest Coverage 21.82
Cash Conversion 113.05%
Profit Quality 186.2%
Current Ratio 2
Quick Ratio 1.64
Altman-Z 4.34
F-Score5
WACC6.41%
ROIC/WACC1.5
Cap/Depr(3y)69.79%
Cap/Depr(5y)66.81%
Cap/Sales(3y)1.34%
Cap/Sales(5y)1.25%
Profit Quality(3y)82.15%
Profit Quality(5y)91.52%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y11.57%
EPS 5Y14.31%
EPS Q2Q%-16.98%
EPS Next Y-7.28%
EPS Next 2Y-1.22%
EPS Next 3Y2.52%
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y8.34%
Revenue growth 5Y8.24%
Sales Q2Q%2.17%
Revenue Next Year-0.79%
Revenue Next 2Y1.9%
Revenue Next 3Y3.29%
Revenue Next 5Y2.91%
EBIT growth 1Y-4.28%
EBIT growth 3Y13.87%
EBIT growth 5Y16.36%
EBIT Next Year27.28%
EBIT Next 3Y13.41%
EBIT Next 5Y10.1%
FCF growth 1Y1190.54%
FCF growth 3Y12.48%
FCF growth 5Y33.59%
OCF growth 1Y1895.19%
OCF growth 3Y13.08%
OCF growth 5Y26.71%